Clinical trial
Effects of Ramelteon on Driving Ability
NCT00319215 · Utrecht Institute for Pharmaceutical Sciences, Other · Completed
Key facts
| NCT number | NCT00319215 |
|---|---|
| Title | Effects of Ramelteon on Driving Ability |
| Official title | A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood |
| Lead sponsor | Utrecht Institute for Pharmaceutical Sciences, Other |
| Collaborators | Takeda Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | Ramelteon 8 mg, Zopiclone 7.5 mg |
| Enrollment | 30 |
| Start date | Mar 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Apr 25, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: